APA (7th ed.) Citation

Kun Dong, Guan Wang, Zeng Liang Wang, & Xueyan Wang. (2019). Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma. Bangladesh Pharmacological Society.

Chicago Style (17th ed.) Citation

Kun Dong, Guan Wang, Zeng Liang Wang, and Xueyan Wang. Efficacy and Safety of Regorafenib Versus Dinutuximab with Chemotherapy in Chinese Children with Neuroblastoma. Bangladesh Pharmacological Society, 2019.

MLA (9th ed.) Citation

Kun Dong, et al. Efficacy and Safety of Regorafenib Versus Dinutuximab with Chemotherapy in Chinese Children with Neuroblastoma. Bangladesh Pharmacological Society, 2019.